Surgery Partners, Inc.
SGRY
$22.80
$0.301.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.24B | 3.17B | 3.11B | 2.99B | 2.89B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.24B | 3.17B | 3.11B | 2.99B | 2.89B |
| Cost of Revenue | 2.47B | 2.42B | 2.37B | 2.28B | 2.20B |
| Gross Profit | 768.60M | 752.20M | 745.60M | 705.60M | 693.90M |
| SG&A Expenses | 137.30M | 141.50M | 138.70M | 123.60M | 131.20M |
| Depreciation & Amortization | 160.70M | 155.20M | 152.60M | 149.80M | 128.50M |
| Other Operating Expenses | -13.60M | -18.00M | -20.00M | -15.00M | -14.00M |
| Total Operating Expenses | 2.75B | 2.70B | 2.64B | 2.54B | 2.44B |
| Operating Income | 484.20M | 473.50M | 474.30M | 447.20M | 448.20M |
| Income Before Tax | 128.60M | 118.10M | 147.10M | 125.60M | 147.50M |
| Income Tax Expenses | 124.20M | 130.20M | 134.60M | 19.80M | 18.40M |
| Earnings from Continuing Operations | 4.40 | -12.10 | 12.50 | 105.80 | 129.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -184.80M | -181.30M | -180.60M | -166.40M | -162.90M |
| Net Income | -180.40M | -193.40M | -168.10M | -60.60M | -33.80M |
| EBIT | 484.20M | 473.50M | 474.30M | 447.20M | 448.20M |
| EBITDA | 644.90M | 628.70M | 626.90M | 597.00M | 576.70M |
| EPS Basic | -1.43 | -1.53 | -1.33 | -0.48 | -0.27 |
| Normalized Basic EPS | -0.10 | -0.05 | 0.02 | 0.00 | 0.03 |
| EPS Diluted | -1.43 | -1.53 | -1.33 | -0.48 | -0.27 |
| Normalized Diluted EPS | -0.10 | -0.05 | 0.02 | 0.00 | 0.03 |
| Average Basic Shares Outstanding | 505.96M | 505.12M | 504.49M | 504.05M | 503.63M |
| Average Diluted Shares Outstanding | 505.96M | 505.12M | 504.49M | 504.05M | 503.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |